China’s Pharmaceutical Industry Emerges as a Global Innovator Amid Strategic Challenges
China’s pharmaceutical sector is transitioning from a low-cost domestic producer to a significant global innovator, driven by extensive investments and a large domestic market. While regulatory and geopolitical hurdles remain, the industry is poised to accelerate its international influence and reshape global pharmaceutical competition.